Clinical Trials Directory

Trials / Sponsors / Corixa Corporation

Corixa Corporation

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
UnknownA Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Phase 32004-04-01
UnknownSafety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small
Non-Small Cell Lung Cancer
Phase 12003-05-01
UnknownSafety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following Fir
Non-Hodgkin's Lymphoma
Phase 22000-01-01
UnknownSafety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Phase 11999-07-01
UnknownSafety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvem
Non-Hodgkin's Lymphoma
Phase 11999-05-01
UnknownExpanded Access Study of Iodine-131 Anti-B1 Antibody
Non-Hodgkin's Lymphoma
N/A1998-09-01
UnknownSafety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Ly
Non-Hodgkin's Lymphoma
N/A—
CompletedSafety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
Mantle Cell Lymphoma
Phase 2—